DNA methylation analysis in MSC therapy

Not Applicable

Recruiting

• Conditions: D001930; brain injury etc

• Registration Number: JPRN-jRCT1010220030
• Lead Sponsor: Sasaki Masanori

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients newly admitted to Sapporo Medical University Hospital for the administration of MSCs who are able to obtain consent will be included. The scope of the study includes physician-initiated clinical trials using MSCs (STR01-01, STR01-02, STR01-03, STR01-04, STR01-05, and STR01-08 studies) and patients undergoing treatment with Stemilac Injection who are judged to be capable of safely obtaining blood samples. Subjects.

Exclusion Criteria

(1) Cases in which consent to participate in the research could not be obtained.
(2). cases in which it is considered difficult to collect specimens safely.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DNAge (DNAge Epigenetic Aging Clock)